Skip to main content

Advertisement

Fig. 3 | EJNMMI Research

Fig. 3

From: Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model

Fig. 3

Tumor growth curves (a) and Kaplan-Meier endpoint-survival curves (b) of U87MG tumor-bearing mice after single injection of the vehicle solution (control) or 37 MBq of 64Cu-RaftRGD, 64Cu-ATSM, or a combination (18.5 MBq for each agent). n = 6/group; *P < 0.01 and P < 0.05 for the combination group vs. control group and vs. 64Cu-RaftRGD or 64Cu-ATSM group, respectively

Back to article page